Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The acetylcholine receptor beta1 subunit is a component of the muscle-type nicotinic acetylcholine receptor (nAChR), a ligand-gated ion channel that mediates synaptic transmission at neuromuscular junctions. It is essential for muscle contraction and mutations are associated with congenital myasthenic syndromes.
Agonist or antagonist binding to the acetylcholine receptor, modulating ion channel activity
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Acetylcholine receptor subunit beta 1 (CHRNB1).